Results 141 to 150 of about 774,595 (263)
Tumor mutational burden as a determinant of metastatic dissemination patterns
Molecular Oncology, EarlyView.This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Mother-Child Relationship Quality in the Presence of Maternal Mental Disorders: Do Self-Report and Behavioural Observation Differ? [PDF]
Clin Psychol PsychotherJung A +4 more
europepmc +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Introduction to the Special Issue: Prevalence and Characteristics of Child Sexual Abuse Perpetration in Australia, the United States, and United Kingdom. [PDF]
J Interpers ViolenceSalter M, Woodlock D, Whitten T.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Molecular Oncology, EarlyView.Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
The effect of online mindfulness training on connectedness to oneself, to others and to nature in students. [PDF]
Appl Psychol Health Well BeingJansen P, Hoja S, Cassar L, Neu TM.
europepmc +1 more source